Carlon G C, Scheiner E, Colaco F M, Howland W S, Goldiner P L
Crit Care Med. 1979 Jan;7(1):1-4. doi: 10.1097/00003246-197901000-00001.
Fifty-seven cancer patients, who had had an 8--15% loss of body weight in the previous 6 months, were studied to establish the reliabity in wasted individuals of presently available nomograms correlating serum creatinine with creatinine clearance. Other predictors of renal function, such as osmolar clearance, free water clearance, and excreted fraction of filtered sodium, were also considered. In all patients, and especially in those with a measured creatinine clearance 10--50 ml/min, the use of standard nomograms based on serum creatinine resulted in gross overestimation of renal function. None of the other tests of renal function proved reliable for clinical purposes. It is concluded that in wasted patients administration of nephrotoxic drugs that are renally excreted should be adjusted to measured creatine clearance. Using other common predictors of renal function may result in overdosage.
对57名癌症患者进行了研究,这些患者在过去6个月内体重减轻了8%至15%,目的是确定目前可用的将血清肌酐与肌酐清除率相关联的列线图在消瘦个体中的可靠性。还考虑了其他肾功能预测指标,如渗透清除率、自由水清除率和滤过钠排泄分数。在所有患者中,尤其是肌酐清除率测量值为10至50毫升/分钟的患者中,使用基于血清肌酐的标准列线图会导致对肾功能的严重高估。没有其他肾功能测试被证明对临床目的可靠。结论是,在消瘦患者中,经肾脏排泄的肾毒性药物的给药应根据测量的肌酐清除率进行调整。使用其他常见的肾功能预测指标可能会导致用药过量。